Quality of Life, Symptoms and Treatment Satisfaction in Adult Patients With Relapsed and/or Refractory Multiple Myeloma, Receiving Ixazomib (Ninlaro®) in Combination With Lenalidomide and Dexamethasone in a Real World Setting: Pilot Study
Conditions
- Relapsed and/or Refractory Multiple Myeloma
Interventions
- DRUG: ixazomib in combination with lenalidomide and dexamethasone
Sponsor
Multinational Center for Quality of Life Research, Russia